Weighted Average Number of Shares Outstanding, Basic of IGC Pharma, Inc. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
IGC Pharma, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • IGC Pharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 90,457,910, a 19% increase year-over-year.
  • IGC Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 76,517,175, a 30% increase from 2023.
  • IGC Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 58,839,868, a 12% increase from 2022.
  • IGC Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 52,576,258, a 5.2% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

IGC Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 90,457,910 +14,450,781 +19% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 83,027,117 +10,213,579 +14% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q1 2025 76,517,175 +17,677,307 +30% 01 Jan 2025 31 Mar 2025 10-K 27 Jun 2025 2025 FY
Q4 2024 77,633,004 +13,907,920 +22% 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025 2025 Q3
Q3 2024 76,007,129 +21,706,042 +40% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2026 Q2
Q2 2024 72,813,538 +19,736,102 +37% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2026 Q1
Q1 2024 58,839,868 +6,263,610 +12% 01 Jan 2024 31 Mar 2024 10-K 27 Jun 2025 2025 FY
Q4 2023 63,725,084 +10,650,961 +20% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2025 Q3
Q3 2023 54,301,087 +2,106,989 +4% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2025 Q2
Q2 2023 53,077,436 +1,460,838 +2.8% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2025 Q1
Q1 2023 52,576,258 01 Jan 2023 31 Mar 2023 10-K 24 Jun 2024 2024 FY
Q4 2022 53,074,123 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q3
Q3 2022 52,194,098 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2024 Q2
Q2 2022 51,616,598 +3,705,732 +7.7% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2024 Q1
Q2 2021 47,910,866 +7,721,644 +19% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2023 Q1
Q2 2020 40,189,222 +681,112 +1.7% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2022 Q1
Q4 2019 39,571,407 +27,927 +0.07% 01 Oct 2019 31 Dec 2019 10-Q 10 Feb 2020 2020 Q3
Q2 2019 39,508,110 +8,526,688 +28% 01 Apr 2019 30 Jun 2019 10-Q 19 Aug 2020 2021 Q1
Q4 2018 39,543,480 +11,374,188 +40% 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020 2020 Q3
Q2 2018 30,981,422 +5,116,115 +20% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2020 Q1
Q1 2018 27,937,287 +2,278,743 +8.9% 01 Jan 2018 31 Mar 2018 10-K 14 Jun 2019 2019 FY
Q4 2017 28,169,292 +723,197 +2.6% 01 Oct 2017 31 Dec 2017 10-Q 20 Feb 2018 2018 Q3
Q3 2017 27,355,826 +3,719,423 +16% 01 Jul 2017 30 Sep 2017 10-Q 17 Nov 2017 2018 Q2
Q2 2017 25,865,307 +2,553,251 +11% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018 2019 Q1
Q1 2017 25,658,544 +9,271,254 +57% 01 Jan 2017 31 Mar 2017 10-K 21 Jun 2018 2018 FY
Q4 2016 27,446,095 +11,221,189 +69% 01 Oct 2016 31 Dec 2016 10-Q 20 Feb 2018 2018 Q3
Q3 2016 23,636,403 +8,641,273 +58% 01 Jul 2016 30 Sep 2016 10-Q 17 Nov 2017 2018 Q2
Q2 2016 23,312,056 +8,479,991 +57% 01 Apr 2016 30 Jun 2016 10-Q 18 Aug 2017 2018 Q1
Q1 2016 16,387,290 +1,631,397 +11% 01 Jan 2016 31 Mar 2016 10-K 14 Jul 2017 2017 FY
Q4 2015 16,224,906 +3,762,493 +30% 01 Oct 2015 31 Dec 2015 10-Q 21 Feb 2017 2017 Q3
Q3 2015 14,995,130 +2,767,601 +23% 01 Jul 2015 30 Sep 2015 10-Q 21 Nov 2016 2017 Q2
Q2 2015 14,832,065 +4,657,707 +46% 01 Apr 2015 30 Jun 2015 10-Q 16 Aug 2016 2017 Q1
Q1 2015 14,755,893 +6,550,209 +80% 01 Jan 2015 31 Mar 2015 10-K 14 Jul 2016 2016 FY
Q4 2014 12,462,413 +4,727,969 +61% 01 Oct 2014 31 Dec 2014 10-Q 16 Feb 2016 2016 Q3
Q3 2014 12,227,529 +5,111,349 +72% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015 2016 Q2
Q2 2014 10,174,358 +3,171,335 +45% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2016 Q1
Q1 2014 8,205,684 +1,238,886 +18% 01 Jan 2014 31 Mar 2014 10-K 14 Jul 2015 2015 FY
Q4 2013 7,734,444 +1,728,270 +29% 01 Oct 2013 31 Dec 2013 10-Q 12 Feb 2015 2015 Q3
Q3 2013 7,116,180 +1,110,006 +18% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014 2015 Q2
Q2 2013 7,003,023 +3,097,089 +79% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2015 Q1
Q1 2013 6,966,798 +4,057,862 +139% 01 Jan 2013 31 Mar 2013 10-K 15 Jul 2014 2014 FY
Q4 2012 6,006,174 -15,294,918 -72% 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014 2013 Q3
Q3 2012 6,006,174 -14,954,259 -71% 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013 2013 Q2
Q2 2012 3,905,934 -16,453,668 -81% 01 Apr 2012 30 Jun 2012 10-Q 16 Aug 2013 2013 Q1
Q1 2012 2,908,936 01 Jan 2012 31 Mar 2012 10-K 15 Jul 2014 2013 FY
Q4 2011 21,301,092 01 Oct 2011 31 Dec 2011 10-Q 13 Feb 2013 2012 Q3
Q3 2011 20,960,433 +7,533,413 +56% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012 2012 Q2
Q2 2011 20,359,602 +7,103,175 +54% 01 Apr 2011 30 Jun 2011 10-Q/A 21 Aug 2012 2012 Q1
Q3 2010 13,427,020 01 Jul 2010 30 Sep 2010 10-Q 18 Nov 2011 2011 Q2
Q2 2010 13,256,427 01 Apr 2010 30 Jun 2010 10-Q 18 Aug 2011 2011 Q1

IGC Pharma, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 76,517,175 +17,677,307 +30% 01 Apr 2024 31 Mar 2025 10-K 27 Jun 2025 2025 FY
2023 58,839,868 +6,263,610 +12% 01 Apr 2023 31 Mar 2024 10-K 27 Jun 2025 2025 FY
2022 52,576,258 +2,584,627 +5.2% 01 Apr 2022 31 Mar 2023 10-K 24 Jun 2024 2024 FY
2021 49,991,631 +8,028,249 +19% 01 Apr 2021 31 Mar 2022 10-K 07 Jul 2023 2023 FY
2020 41,963,382 +2,473,368 +6.3% 01 Apr 2020 31 Mar 2021 10-K 23 Jun 2022 2022 FY
2019 39,490,014 +4,096,607 +12% 01 Apr 2019 31 Mar 2020 10-K 14 Jun 2021 2021 FY
2018 35,393,407 +7,456,120 +27% 01 Apr 2018 31 Mar 2019 10-K 13 Jul 2020 2020 FY
2017 27,937,287 +2,278,743 +8.9% 01 Apr 2017 31 Mar 2018 10-K 14 Jun 2019 2019 FY
2016 25,658,544 +9,271,254 +57% 01 Apr 2016 31 Mar 2017 10-K 21 Jun 2018 2018 FY
2015 16,387,290 +1,631,397 +11% 01 Apr 2015 31 Mar 2016 10-K 14 Jul 2017 2017 FY
2014 14,755,893 +6,550,209 +80% 01 Apr 2014 31 Mar 2015 10-K 14 Jul 2016 2016 FY
2013 8,205,684 +1,238,886 +18% 01 Apr 2013 31 Mar 2014 10-K 14 Jul 2015 2015 FY
2012 6,966,798 +4,057,862 +139% 01 Apr 2012 31 Mar 2013 10-K 15 Jul 2014 2014 FY
2011 2,908,936 -12,199,984 -81% 01 Apr 2011 31 Mar 2012 10-K 15 Jul 2014 2013 FY
2010 15,108,920 01 Apr 2010 31 Mar 2011 10-K 16 Jul 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.